Stifel analyst Parker Lane maintains Everbridge (NASDAQ:EVBG) with a Hold and raises the price target from $32 to $38.
Psychedelic Subsidiaries News: Blackhawk Spins Out Three Companies, Algernon Creates A New One
The psychedelics space is up and running. Together with the start of the new year, two companies have shared their latest financial decisions toward advancing their medical business programs.